2020 American Transplant Congress
Comparative Proteomics Analysis Identifies L-FABP as a Putative Biomarker of Graft Injury During Liver Transplantation Using the ITRAQ/MRM Approach
Transplant Center, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: In liver transplantation, much of factors have a pernicious influence on liver donor quality, such as hepatic steatosis, long term of donor hypotension, cardiac…2020 American Transplant Congress
Treatment Strategies to Suppress Donor Specific Antibodies: Highlights from a Decade of Research Experience in a Mouse Model of Allo-Sensitization
Cedars-Sinai Med Ctr, Los Angeles, CA
*Purpose: Difficulty in desensitization in highly sensitized patients remain problematic in organ transplantation. For over 12 years, our laboratory has been carrying out an HLA…2020 American Transplant Congress
Deceased Donor Body Temperature is Associated with Delayed Graft Function in Kidney Transplant Recipients
*Purpose: Delayed graft function (DGF) among kidney transplant recipients complicates the post-operative course and is associated with graft failure. Intentional cooling of the donor may…2020 American Transplant Congress
Sirolimus (SRL) versus Everolimus (EVR) versus Mycophenolate (MPA) in Kidney Transplant Recipients Receiving Anti-Thymocyte Globulin Induction (r-ATG), Tacrolimus (TAC), and Prednisone
Nephrology Division, Hospital Do Rim, Sao Paulo, Brazil
*Purpose: The aim of this study is to compare the efficacy and safety of SRL versus EVR versus MPA in kidney transplant recipients*Methods: This is…2020 American Transplant Congress
Graft and Patient Survival after A2-Incompatible Deceased Donor Kidney Transplantation
Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: The Kidney Allocation System (KAS), implemented in 2014, increased offers of ABO type A2 donor kidneys to type O and B recipients, and A2B…2020 American Transplant Congress
Long-Term Outcomes for Living Kidney Donors: A Japanese Single-Center Experience
Urology, Hokkaido University Hospital, Sapporo, Japan
*Purpose: Previous studies suggested that live kidney donors do not have a higher risk of death or end-stage kidney disease (ESKD) than the general population.…2020 American Transplant Congress
Outcomes of Early versus Late Rejection in Kidney Transplant Recipients
*Purpose: Advances in immunosuppression have resulted in significantly improved acute rejection rates and short-term renal graft survival. Several studies have suggested that late rejection (LR)…2020 American Transplant Congress
Frailty at Time of Kidney Transplant Evaluation is Associated with Higher Rate of Waitlist Denial
*Purpose: To determine the association of patient frailty, as assessed by the Fried frailty score at the time of kidney transplant evaluation (KTE), with kidney…2020 American Transplant Congress
Pre- And Post-Transplant (Tx) Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody) Treatment Increased Regulatory T Cell (Treg) Percentage in CD4+ T Cells in HLA-Sensitized Kidney Transplant Patients (HS KTx Pts)
*Purpose: IL-6 is a B cell growth factor and pro-inflammatory cytokine. Inhibition of IL-6 signaling modulates B cell activation and inflammatory process possibly through Treg…2020 American Transplant Congress
Belatacept in Kidney Transplant Recipients with Previous Non-Renal Solid Organ Transplants
Emory Transplant Center, Emory University School of Medicine, Atlanta, GA
*Purpose: Selective co-stimulatory blockade with belatacept has demonstrated long-term benefits in renal transplantation, with improved glomerular filtration rate and decreased risk of death and graft…
- « Previous Page
- 1
- …
- 151
- 152
- 153
- 154
- 155
- …
- 223
- Next Page »